OPKO Health Inc- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 OPKO Health Inc 公司

OPKO Health, Inc. 是一家跨國生物製藥和診斷公司。該公司專注於利用其發現、開發和商業化專業知識以及新穎的專有技術。其部門包括製藥和診斷。製藥部門包括其在智利、墨西哥、愛爾蘭、以色列和西班牙的製藥業務、Rayaldee 產品銷售及其製藥研發。診斷部門主要包括即時診斷業務。其製藥業務包括 Rayaldee，一種經美國食品藥品管理局 (FDA) 批准的治療患有三期或四期慢性腎病 (CKD) 和維生素 D 不足的成人繼發性甲狀旁腺功能亢進症 (SHPT) 的藥物，以及 Somatrogon (hGH-CTP)，一種每週注射一次的人類生長激素注射劑。其 NGENLA (somatrogon-ghla) 是一種每週注射一次的人類生長激素類似物，適用於治療三歲及以上的兒科患者。

OPKO Health Inc簡介



公司代碼OPK

公司名稱OPKO Health Inc

上市日期Nov 02, 1995

CEODr. Tony F. Cruz, Ph.D.

員工數量2997

證券類型Ordinary Share

年結日Nov 02

公司地址- -

城市- -

上市交易所NASDAQ Global Select Consolidated

國家- -

郵編- -

電話- -

網址- -

公司代碼OPK

上市日期Nov 02, 1995

CEODr. Tony F. Cruz, Ph.D.

OPKO Health Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Jane H. Hsiao, Ph.D.

Vice Chairman of the Board, Chief Technical Officer

33.13M

--

Mr. Steven D. (Steve) Rubin, Esq., J.D.

Executive Vice President - Administration, Director

6.19M

-6.60%

Mr. John A. Paganelli

Independent Director

393.51K

--

Mr. Adam E. Logal

Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer

179.16K

-70.95%

Dr. Richard M. Krasno, Ph.D.

Independent Director

103.33K

--

Dr. Elias A. Zerhouni, M.D.

President, Vice Chairman of the Board

89.60K

-84.80%

Dr. Alice Lin-Tsing Yu, M.D., Ph.D.

Independent Director

66.49K

--

Mr. Richard C. (Rick) Pfenniger, Jr.

Independent Director

--

Dr. Tony F. Cruz, Ph.D.

Chief Executive Officer, Transition Therapeutics, Inc

--

Dr. Roger J. Medel, M.D.

Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Jane H. Hsiao, Ph.D.

Vice Chairman of the Board, Chief Technical Officer

33.13M

--

Mr. Steven D. (Steve) Rubin, Esq., J.D.

Executive Vice President - Administration, Director

6.19M

-6.60%

Mr. John A. Paganelli

Independent Director

393.51K

--

Mr. Adam E. Logal

Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer

179.16K

-70.95%

Dr. Richard M. Krasno, Ph.D.

Independent Director

103.33K

--

Dr. Elias A. Zerhouni, M.D.

President, Vice Chairman of the Board

89.60K

-84.80%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Health Insurers

58.48M

57.84%

Client Payers

23.17M

22.92%

Government Payers

17.10M

16.92%

Patients

2.35M

2.33%

地區USD

名稱

營收

佔比

United States

114.88M

73.26%

Chile

16.00M

15.83%

Ireland

11.74M

11.61%

Spain

6.72M

6.65%

Mexico

6.30M

6.23%

其他

-54.55M

-13.59%

業務

地區

業務USD

名稱

營收

佔比

Health Insurers

58.48M

57.84%

Client Payers

23.17M

22.92%

Government Payers

17.10M

16.92%

Patients

2.35M

2.33%

股東統計

更新時間: 8月16日週六

持股股東

股東類型

持股股東

佔比

Frost Gamma Investments Trust

28.70%

Rubric Capital Management LP

6.23%

Holbrook (Bruce C)

5.26%

The Vanguard Group, Inc.

4.97%

Hsiao (Jane H)

4.32%

其他

50.53%

持股股東

佔比

Frost Gamma Investments Trust

28.70%

Rubric Capital Management LP

6.23%

Holbrook (Bruce C)

5.26%

The Vanguard Group, Inc.

4.97%

Hsiao (Jane H)

4.32%

其他

50.53%

股東類型

持股股東

佔比

Corporation

37.85%

Investment Advisor

12.39%

Individual Investor

10.57%

Hedge Fund

7.62%

Investment Advisor/Hedge Fund

5.83%

Research Firm

1.05%

Bank and Trust

0.16%

Pension Fund

0.12%

Family Office

0.02%

其他

24.39%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

455

208.86M

27.21%

-55.45M

2025Q2

472

618.23M

77.88%

-578.48K

2025Q1

498

645.32M

88.41%

+25.74M

2024Q4

501

573.04M

84.80%

-7.63M

2024Q3

497

562.18M

81.01%

-12.00M

2024Q2

501

553.77M

79.70%

+8.59M

2024Q1

492

531.83M

76.52%

-21.84M

2023Q4

493

533.01M

69.65%

+31.42M

2023Q3

496

529.79M

69.24%

+23.70M

2023Q2

502

536.53M

70.13%

+25.42M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Frost Gamma Investments Trust

220.16M

27.74%

+360.00K

+0.16%

Sep 30, 2025

Rubric Capital Management LP

47.79M

6.02%

-915.40K

-1.88%

Jun 30, 2025

Holbrook (Bruce C)

40.38M

5.09%

--

Feb 24, 2025

The Vanguard Group, Inc.

38.16M

4.81%

+8.74M

+29.70%

Jun 30, 2025

Hsiao (Jane H)

33.13M

4.17%

--

Apr 02, 2025

Frost Group, L.L.C.

30.13M

3.8%

--

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

28.22M

3.55%

+3.45M

+13.93%

Jun 30, 2025

GJN 2021 Trust

19.91M

2.51%

--

Feb 24, 2025

EGN 2021 Trust

19.91M

2.51%

--

Feb 24, 2025

Geode Capital Management, L.L.C.

10.42M

1.31%

+2.00M

+23.68%

Jun 30, 2025

持股ETF



更新時間: 11月2日週日

機構名稱

佔比

Invesco NASDAQ Future Gen 200 ETF

0.55%

SPDR S&P Health Care Services ETF

0.49%

VanEck Israel ETF

0.15%

Humankind US Stock ETF

0.11%

iShares U.S. Healthcare Providers ETF

0.11%

Goldman Sachs Innovate Equity ETF

0.08%

iShares MSCI USA Small-Cap Min Vol Factor ETF

0.06%

iShares Biotechnology ETF

0.05%

iShares Russell 2000 Value ETF

0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.04%

Invesco NASDAQ Future Gen 200 ETF

佔比0.55%

SPDR S&P Health Care Services ETF

佔比0.49%

VanEck Israel ETF

佔比0.15%

Humankind US Stock ETF

佔比0.11%

iShares U.S. Healthcare Providers ETF

佔比0.11%

Goldman Sachs Innovate Equity ETF

佔比0.08%

iShares MSCI USA Small-Cap Min Vol Factor ETF

佔比0.06%

iShares Biotechnology ETF

佔比0.05%

iShares Russell 2000 Value ETF

佔比0.04%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.04%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據